Pyrovalerone
Also called Pirovalerona
Overview
Pyrovalerone (Centroton, 4-Methyl-β-keto-prolintane, Thymergix, O-2371) is a central nervous system (CNS) stimulant that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). It was developed in the 1980s and had briefly been approved in Spain and France for chronic fatigue or lethargy and as an appetite suppressant, but was withdrawn from both markets around 2001 due to safety concerns including problems with abuse and dependence. It is closely related on a structural level to a number of other cathinone stimulants, such as α-PVP, MDPV and prolintane.[1]
Side effects of pyrovalerone include decreased appetite, anxiety, fragmented sleep or insomnia, and trembling, shaking, or muscle tremors. Withdrawal symptoms following abuse upon discontinuation often results in depression. WP
The R-enantiomer of pyrovalerone is devoid of pharmacologic activity.[4] WP
Chemistry
- Formula
- C16H23NO PC
- CAS number
- 3563-49-3 PC
- Molar mass (g/mol)
- 245.36 PC
- IUPAC name (computed by PubChem)
- 1-
(4- PCmethylphenyl) - 2- pyrrolidin- 1- ylpentan- 1- one - SMILES
- CCCC(C(=O)
C1=CC=C(C=C1) PCC) N2CCCC2 - InChIKey
- SWUVZKWCOBGPTH-
UHFFFAOYSA- PCN - PubChem CID
- 14373
- IUPAC name
- (RS)
- WP1- (4- methylphenyl) - 2- (1- pyrrolidinyl) pentan- 1- one
Harm reduction information
No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.
User reports
Erowid erowid.org
ListingsBluelight bluelight.org
ListingsReddit reddit.com
ListingsPop culture
No references added yet.
Add a reference
Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.
Opens when accounts launch.
Sources
- Other US Patent 3314970
- Journal / agency Gardos G, Cole JO. Evaluation of pyrovalerone in chronically fatigued volunteers. Current Therapeutic Research, Clinical and Experimental. October 1971. PMID 4402508
- Journal / agency Deniker P, Lôo H, Cuche H, Roux JM. Abuse of pyrovalerone by drug addicts. Annales médico-psychologiques. November 1975. PMID 9895
- Journal / agency Meltzer PC, Butler D, Deschamps JR, Madras BK. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. Journal of Medicinal Chemistry. February 2006. doi:10.1021/jm050797a · PMID 16480278 · PMC2602954
Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.